What's new

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised

May 13, 2025 - 15:22
 0
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers

Next Article

EMEA-002689-PIP02-23

Related Posts

Human medicines European public assessment report (EPAR): Sunitinib Accord, sunitinib, Date of authorisation: 11/02/2021, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

May 6, 2025  0

NovoSeven (eptacog alfa)

NovoSeven (eptacog alfa)

May 12, 2025  0

Human medicines European public assessment report (EPAR): Tacforius, tacrolimus, Date of authorisation: 08/12/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0